Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

14
Number of overlapping holdings
23.3%
% of XLV's 60 holdings also in FMED
25.5%
% of FMED's 62 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus FMED)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in XLV |
Weight in FMED |
Overlap | |
---|---|---|---|---|
UNITEDHEALTH GROUP INC | 11.1% | 4.0% | 4.0% | |
INTUITIVE SURGICAL INC | 3.5% | 4.5% | 3.5% | |
BOSTON SCIENTIFIC CORP | 2.8% | 7.3% | 2.8% | |
DANAHER CORP | 2.4% | 3.5% | 2.4% | |
STRYKER CORP | 2.4% | 2.8% | 2.4% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to FMED
ELI LILLY & CO | 9.6% | |
JOHNSON & JOHNSON | 7.3% | |
UNITEDHEALTH GROUP INC | 7.1% | |
ABBVIE INC | 6.2% | |
ABBOTT LABORATORIES | 4.4% | |
MERCK & CO. INC. | 4.0% | |
AMGEN INC | 3.1% | |
GILEAD SCIENCES INC | 2.6% | |
VERTEX PHARMACEUTICALS INC | 2.5% | |
PFIZER INC | 2.5% |
XLV Underweight Relative to FMED
BOSTON SCIENTIFIC CORP | -4.5% | |
INSULET CORP | -4.0% | |
ARGENX SE ADR | -3.4% | |
PENUMBRA, INC. | -3.2% | |
UCB SA | -2.8% | |
AGILON HEALTH INC | -2.8% | |
ALNYLAM PHARMACEUTICALS INC | -2.8% | |
LIFESTANCE HEALTH GROUP, INC. | -2.6% | |
EXACT SCIENCES CORP | -2.6% | |
LEGEND BIOTECH CORPORATION SPONSORED | -2.5% |